Name | 5-bromopyrimidine-4-carbonitrile |
---|---|
Synonyms |
4-Pyrimidinecarbonitrile, 5-bromo-
5-BROMO-4-CYANOPYRIMIDINE 4-PYRIMIDINECARBONITRILE,5-BROMO 5-bromopyrimidine-4-carbonitrile 5-Bromo-4-pyrimidinecarbonitrile 4-CYANO-5-BROMOPYRIMIDINE |
Density | 1.9±0.1 g/cm3 |
---|---|
Boiling Point | 328.6±27.0 °C at 760 mmHg |
Molecular Formula | C5H2BrN3 |
Molecular Weight | 183.993 |
Flash Point | 152.5±23.7 °C |
Exact Mass | 182.943207 |
PSA | 49.57000 |
LogP | 0.71 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.618 |
HS Code | 2933599090 |
---|
~19% 114969-66-3 |
Literature: AstraZeneca AB; NPS PHARMACEUTICALS, INC. Patent: US2007/37820 A1, 2007 ; Location in patent: Page/Page column 14 ; US 20070037820 A1 |
~21% 114969-66-3 |
Literature: Yamanaka, Hiroshi; Sakamoto, Takao; Nishimura, Sumiko; Sagi, Mataichi Chemical and Pharmaceutical Bulletin, 1987 , vol. 35, # 8 p. 3119 - 3126 |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |